chrisvoncsefalvay/vaers-outcomes huggingface dataset:
right outer thigh has 2 purple bruises; Yesterday they were kneeling and now they have bruises in both knees; increased bruising of the skin; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (increased bruising of the skin), CONTUSION (Yesterday they were kneeling and now they have bruises in both knees) and CONTUSION (right outer thigh has 2 purple bruises) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced CONTUSION (increased bruising of the skin). On 20-Apr-2021, the patient experienced CONTUSION (Yesterday they were kneeling and now they have bruises in both knees). On 21-Apr-2021, the patient experienced CONTUSION (right outer thigh has 2 purple bruises). At the time of the report, CONTUSION (increased bruising of the skin), CONTUSION (Yesterday they were kneeling and now they have bruises in both knees) and CONTUSION (right outer thigh has 2 purple bruises) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  Concomitant medication was not provided Treatment information was not provided
p/vax pt w/fever, some swelling & redness 10/27/99; 10/28 pt unable to walk, bear weight on leg;called MD; awake & crying all noc; to office in AM;unable to bear weight;swollen & very red from knee up thigh;to hosp;
She got her vaccine, her arm hurt.  During the middle of night had SOB for about a minute, gasping for air.  Then around 6-7 AM had numbness in her hands, tingling like they were asleep.  When she walked her feet hurt and felt like she had plantar fasciitis or Morton's neuroma on the balls of her feet.  The tips of her fingers hurt and get cold very easily even if it's hot out.  The feeling of pain and also had feeling of swelling but they did not look swollen.  The symptoms are not as bad as they were but she has had a 4 day weekend and has not used them as much as she has rested.  Her doctor did not want to discuss it as it was vaccine related and told her to call the CDC, which she has contacted us.  She has not gotten her 2nd vaccine and does not know if she should or not and was calling us for that info, which I gave her the manufacturer phone # to contact them.
dose #1-Nausea, fever one day after shot same day-lightheaded, queasy Dose #2 severe queasiness, lightheaded, nausea
Patient received DTAP & IPV at his routine 4 yr old visit. Patient was well and went home. Roughly 35 minutes later mom called and says he has a rash. He returned to the office and was not to have hives at Right eye to Right periorbital edema, wheezing. Retractions and a rash at his neck. Patient received a Xopomex 1.25mg BID nebulizer and Oraped 30 mg by mouth one time and wheezing resolved. Over 30 minute observation, hives-rash improved. Wheezing did not resume.
Pulmonary embolism and blood clot in left leg. Patient did receive the pfizer covid vaccine if February.
At about 9 pm (3/29/13) began to vomit.  Over the next 7 hours had vomited 8 times.  Had NO fever or diarrhea.  3/30/13 had stomach ache, felt dizzy, and felt fatigued. Did not want to get off bed or couch.  4/1/13 Continues to feel tired and fatigued with complaints of stomach still not feeling right-but states it is not an upset stomach feeling. (no one else in home is sick or has been sick with any stomach virus).
30JUL98 swelling lt shoulder & hand;decadron given;numb fingers & arms;3AUg98 still numb forearm & 2 fingers arm swollen;6AUG98 started PT;
hair loss approximately two months after her second vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 31-year-old female patient received BNT162b2 (BNT162B2), in Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, Single), administration date: Mar2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "unknown", described as "hair loss approximately two months after her second vaccine". The event "hair loss approximately two months after her second vaccine" required physician office visit. Therapeutic measures were taken as a result of alopecia.  Additional information: Reporter reported that her daughter had been to an endocrinologist, a dermatologist who specializes in hair loss with a hair and scalp fellowship, and an immunological dermatologist, for the purpose of finding out what was going on with the hair loss. She stated that her daughter tried quite a few things, but nothing seems be working. She stated that her daughter tried vitamins and nutritional supplements mainly, and she took some iron supplements and B12 supplements. NDC/LOT/EXP: Unknown for the B12 and iron supplements that the patient took. She stated that she took those only after the hair loss for the purpose of trying to help the hair loss. She says she lives in a different state, so she doesn't know the dosage her daughter took, only that it was within recommended dosing. Reporter reported that her daughter started to notice the hair loss approximately two months after her second vaccine, and noticed it increased about two months after the third vaccination. She stated that it got worse after the third vaccination, and doesn't seem to have slowed much, between that it had waxed and waned.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
4/21/21 I started having mobility issues, I sae a chiropractor and massage therapist for treatment, as I have flare ups occasionally(fibromyalgia).  This "flare up" didn't go away as normal even after 2 visits(4/21/21 and 4/24/21). I was in the ER on 4/21/21 for inability to walk, weakness, numbness, tingling, severe back pain and high fever. I stayed in hospital until 4/24/21 and returned 4/30/21 until 5/1/21 when I couldn't control bladder or bowel movements. I currently am still unable to walk without a walker and also still having bladder issues.
Patient went to ER on Oct 14/07. Injection site she had turned red, swelled, painful. Doctor assessed as cellulitis, gave Bactrim DS and Percocet. Patient did followup with family doctor symptoms slowly getting better.
Shingles right eye; Shingles right side of face; swelling left side of face; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OPHTHALMIC HERPES ZOSTER (Shingles right eye) and HERPES ZOSTER (Shingles right side of face) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A29A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced OPHTHALMIC HERPES ZOSTER (Shingles right eye) (seriousness criterion medically significant), HERPES ZOSTER (Shingles right side of face) (seriousness criterion intervention required) and SWELLING FACE (swelling left side of face). At the time of the report, OPHTHALMIC HERPES ZOSTER (Shingles right eye), HERPES ZOSTER (Shingles right side of face) and SWELLING FACE (swelling left side of face) outcome was unknown.            No concomitant medication were reported.  On 27 Mar 2021, the patient reported "face blew up". The patient also mentioned that she had no other adverse reactions. The patient went to see the ophthalmologist and dermatologist on 06-Apr-2021 and was prescribed valaciclovir (Valtrex). On 07-Apr-2021, the patient saw another eye specialist and was prescribed prednisone. Treatment included for the events were valaciclovir and prednisone.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-073451 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt began vomiting profusely. She vomited every 10 minutes for 2 1/2 hours. Pediatrician was notified within the first hour that vomiting began due to the severity and frequency. Pt became lethargic and very clingy. Approximately 3 1/2 hours later patient had stopped vomiting and had began to appear more alert. From that time until Monday 6/20/15, Pt would refuse to eat, with total 24 hour intake of 12-16 ounces. Two days later, pt had liquid diarrhea for 24 hours that was very acidic smelling and yellow in color. Stool has firmed at this time yet still has yelllow/greyish tint in color. Pt is fully recovered at this time, however still only taking 20 ounces in 24 hours.
Spoke with Patient regardingside effects following her #1 Covid Vaccine on 1/15/21. She stated that about 12 hours later developed extreme fatigue, all over weakness, headache, she also c/o intermittent numbness & tingling in bilateral lower extremities (mid-calf to toes) she states that she also has Resless Leg Syndrrome that is untreated. Has been in contact with her PCP. Encouraged her to "Self-Report"  to the Vaccine's web-site listed in the Vaccine handout. Encouraged her to call back if she has further concerns or questions.
pt recv vax 25SEP97 & c/o not feeling well since taking the inj, temp was 101, chilling, nauseated & gen malaise by mid day on 25SEP97 sx had subsided;pt advised to go home & to the ER but declined;
About 10 days, post vax, employee developed a low-grade fever (39.1C), chills, slight headache, body aches and body malaise. Then, 2 days after, developed rashes in the face and around the trunk.
received the Covid-19 vaccine at approx 1108am. She reports symptoms of Other: itching, more severe on her upper back.  Pt taken to nurse observation area, placed on cot, HOB up 45 degrees. No hives or welts noted anywhere on body. Denies SOB, swelling of throat or tongue.    Treatment/intervention: 1124 am  Benadryl 25mg capsule given po, after confirming no allergies, per protovol.  Taken and swallowed without difficulty.  Itching at this time rated at 8 of 10.  Vital signs taken:  1122am  SBP 150/90, HR 82, RR 22, Spo2 98% 1124am  Benadryl given 1130am Itching rated a 6/10. No other symptoms. 1145am  SBP 138/88, HR 92, RR 20, SPo2 99% Itching rated a 2/10. No other symptoms. 1205pm Itching completely resolved. Feeling slightly sleepy.
Full dose not administered to patient; The needle came loose from the syringe; A spontaneous report was received from a healthcare professional concerning a patient who was participating in the mRNA-1273 Emergency Use Program and experienced the needle came loose from the syringe and the full dose was not administered to the patient.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   The reporter reported that, the needle came loose from the syringe and the patient did not receive the full dose.  She wanted to know if the patient should receive another dose.   No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.  The events, the needle came loose from the syringe and the full dose was not administered, was considered resolved.  The reporter did not provide a causality assessment of the events, the needle came loose from the syringe and the full dose was not administered.; Reporter's Comments: This case concerns a patient of unknown gender and age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting The needle came loose from the syringe and The patient did not receive the full dose without any associated adverse events.
Pt sat down.  5 minutes later c/o lightheadedness and was very diaphoretic.   1718 108/53 hr 68, rr 16-20, sats 99 1722 - 104/68, hr 92, sats 96.   RRT called.  pt denied dyspnea, itching. Pt transported to ED.
Strong shoulder pain started on Sat 4/17 in the early morning that woke me up. Went away by 10a after taking tylenol and having a coffee. Sun 4/18: pain again woke me up and was more severe. Had to get out of bed to move around as pain was pretty bad. Went to urgent care. Found nothing serious (not a heart attack or clots, etc). Referred me to go see my PCP if it did not resolve in a few days. Thu 4/22: went to PCP. Pain had subsided for the most part, but started having reduced range of motion when lifting arm straight forward...could not get past 90 degrees (straight out) without pain and a feeling of physical binding in the joint. Suspected bursitis. Prescribed a steroid pack and muscle relaxer.  Sat: 4/24: my son noticed my shoulder blade sticking out when attempting to reach for a glass of water while seated. Decided to make appt with an orthopedic. Fri 4/30: went to orthopedic. Took xray. Found no physical damage, trauma, etc. Noticed winged scapula as reason for lack of range of motion. Prescribed physical therapy. Fir 5/14: still same lack of range of motion and no pain. Went to first PT appt. They took range of motion measurements and agreed I was limited. Tested for other pain or signs of trauma and found none. Prescribed a PT regimen.   After my own research combined with symptoms, and no physical trauma as the source. My suspicion is Parsonage Turner Syndrome brought on by the vaccination.
Vaccination failure; Energy still low; Flu; This is a serious spontaneous case, initially received from other health professional on 21-Nov-2018, concerning a 16-year-old, male, adolescent patient.    On 16-Oct-2018, the patient was administered Flucelvax QIVc (influenza vaccine, subunit influenza virus vaccine polyvalent, cell culture derived, batch number: 252664, dose, route of administration, anatomical location and expiry date: not reported) for an unknown indication.  On 21-Nov-2018, 1 month and 5 days after vaccination, the patient experienced low energy and was diagnosed with flu (considered as vaccination failure). A nasal swab test was performed. It was reported that, there was an error in sampling and testing and the diagnosis was determined on the basis of patient's symptoms. The patient was prescribed with Tamiflu (oseltamivir phosphate).  At the time of this report, the patient had not recovered from the event low energy and outcome of the event influenza was not reported.  Follow up received from the reporter on 16-Jan-2019: New reporter was added in the general tab. No changes were made in the narrative.  Non-significant follow-up received on 01-Mar-2019: Reference number (Med Info Number: SEQ19-00552) was added in the additional information tab. It was reported that unsuccessful attempt to follow-up was made on 31-Jan-2019. No new information received. Hence, no changes were made in the narrative.; Reporter's Comments: A 16-year-old male patient was diagnosed with influenza, 1 month and 5 days after receipt of Flucelvax QIVc on the basis of symptoms. Although a nasal swab test was performed, results were unavailable, time to onset is plausible following vaccination with the reported Influenza and vaccination failure events. Hence, company assessed the events as possibly related to suspect vaccine. The company assessed the events (influenza and vaccination failure) assessed as serious (medically significant).
Rectal temperature 101 F, exessive sleepiness, decreases responsiveness for about 24 p/vax, mom had to wake the child up for feedings. No appetite changes. Developmental delays showed up later in life. Child started sitting up at 9.5 months, walked on toes holding on furniture, started walking alone at 18 months, currently shows most significant delays in social interaction, speech and language skills. At age 2 years 5 months 8 days had developmental evaluation and met criteria for a diagnosis of autism.
3rd after 1st rabies vaccine resulted in paresthesias feet, hands, burning pain then myalgias legs,a arms, weakness, occipital headache, dyspnea after total 4 rabies vaccines.  Neurologist diagnosed: Guillain Barre.
pt recv vax & JUL96 lab eval revealed no mumps titer;It was noted that pt was immune to measles & rubella;
Vaccine 12/31/20: Had arm soreness for 2 days then resolved.  Day 9 (1/8/21), I noticed redness (2in x 2 in), hard knot/swelling, warmth to touch, slight itchyness and achyness.   Day 10 (today 1/9/21), swelling went down, itchyness resolved (but redness, warmth, achyness still there).
Fever, 101°F Fatigue, mild Body aches Shivering Headache, moderate Treatment: fluids, rest, Tylenol & ibuprofen, prn Lasted about 24 hours
Fever started 1 hr p/vax; Seen in ER & given suppositories which brought temp down to 101; Pt also went limp & cried 4.5 - 5 hrs straight; Pt had rash around area where HIB was given;
swelling of eyelids; Facial redness; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 02Mar2021 at 12:00 (at the age of 40-years-old) as dose 1, single for COVID-19 immunisation. Medical history included autoimmune disorder from an unknown date. There were no concomitant medications.  The patient previously took hydrocodone/paracetamol (VICODIN) and codeine and had allergies. The patient experienced swelling of eyelids and facial redness on 03Mar2021 at 12:00. Therapeutic measures were taken as a result of the events which included diphenhydramine (BENADRYL). The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Anti-bodies react, huge rash; Burning reaction neck, arms and legs; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash and burning sensation. On an unknown date, the outcome of the rash and burning sensation were recovered/resolved.   It was unknown if the reporter considered the rash and burning sensation to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 8-APR-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine and experienced huge rash and burning reaction on neck, arms and legs for one year. The patient stated that not all anti-bodies reacted smoothly. Additional supportive information: The follow-up would not possible, as no contact details were available.
14NOV91 pt c/o sore throat, chest congestion, fever, fatigue, muscle aches; pt given Emycin x 10 days & deconamine x 10 days;
Hives, Cluster of 2 patients (patient identification provided) with generalized hives throughout the entire body, after receiving Adacel (lot number C2631AA); Fluzone (lot number unknown) and Menactra (lot number U1922AB); received from a health care professional in the USA on 24 April 2007. Case 1: A 12 year old, male patient (with a history of no known allergies) developed generalized hives throughout the entire body, 2 months after she received Adacel (lot number C2631AA), Fluzone (lot number unknown) and Menactra (lot number U1922AB) on 15 February 2007. He has the influenza vaccine annually. The patient denies any illness or medications at the time of the vaccinations. He was treated with Cortisone, Singular and Atarax. It was reported the hives resolved and the patient recovered. The second case ( the patient's sister) is detailed in Case 2007-01400.
Noticed a quarter sized lump at GARDASIL injection site approximately 3 weeks after vaccine was given. Noticed pain to touch and move arm approximately around 08/12/2016. Lump is not getting smaller. There is an indentation in the skin at injection site. Pain is continuing to get worse.
I started getting symptoms of body aches and a slight fever. The second day, the fever was gone then I developed a sore throat. The third day I had issues with sinuses, congestion, and runny nose. I had fatigue for 1 week. I took an at home COVID-19 test that was positive. I went to a clinic and prescribed antibiotics. My sinuses cleared up with the antibiotics.
Fever, fatigue, malaise, papular rash. Rx'd with NSAID, Benadryl and Keflex.
Patient received first dose vaccine and has a blood clotting condition; as a blood clotting condition,She is asking if she is still advisable to get the 2nd dose; has a blood clotting condition ,She is asking if she is still advisable to get the 2nd dose; She is asking if she is still advisable to get the 2nd dose; This is a spontaneous report received from Covax US Support. This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. Ongoing medical history included antiphospholipid syndrome. The patient's concomitant medications included aspirin.   The patient stated she received first dose vaccine and has a blood clotting condition on an unspecified date. It was reported that she is scheduled for the 2nd dose on 20April2021 (exactly 21 days apart). However, she has a blood clotting disorder. She was asking if she is still advisable to get the 2nd dose. The event blood clotting condition was considered as serious (medical significant). It was reported that patient does not have the vaccine card information with her and was unable to provide the lot number. Expiry date of pfizer covid vaccine was unknown. She was given a piece of paper with all the facts on it and it said that there is concern about people with blood clotting or taking products. She has a condition called antiphospholipid Syndrome, a blood clotting disorder. (APS is the abbreviation for caller's blood clot disorder, its an autoimmune disorder, called Antiphospholipid Syndrome). She was asking if AstraZeneca Vaccine had this issue, perhaps a little bit of an issue with other vaccines as well. She made this call to find out what information can be given before receiving her second dose Pfizer Covid Vaccine. She wanted to make sure the benefit is greater than the detriment. She was asking if she is still advisable to get the 2nd dose. Therapeutic measures were taken as a result of patient received first dose vaccine and has a blood clotting condition. The outcome of events were unknown. She wants to know if she can take the second dose and she is taking aspirin for her APS.  No follow-up attempts are needed. No further information is expected
Symptoms started night of 1st pill with severe, hacking cough. Symptoms became worse with each pill intake and included fever (100.0 degrees F - 102.8 degrees F), chills, shortness of breath, sweating, and severe fatigue, and severe headaches. Patient still had one more pill to take before vaccine completed.